GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.837
+0.114 (15.77%)
At close: Apr 28, 2026, 4:00 PM EDT
1.080
+0.243 (29.03%)
Pre-market: Apr 29, 2026, 8:11 AM EDT
GlucoTrack Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
1.63M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 86.55M |
| Retractable Technologies | 38.27M |
| Bionano Genomics | 28.51M |
| Jin Medical International | 20.69M |
| Nephros | 18.79M |
| NEXGEL | 11.42M |
| Milestone Scientific | 8.97M |
| Lucyd | 2.66M |
GCTK News
- 8 days ago - Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology - GlobeNewsWire
- 4 weeks ago - Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 4 weeks ago - Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones - GlobeNewsWire
- 6 weeks ago - GlucoTrack Transcript: EGM 2026 - Transcripts
- 7 weeks ago - Glucotrack to Present at LSI USA '26 Medtech Innovation Summit - GlobeNewsWire
- 3 months ago - Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform - GlobeNewsWire
- 4 months ago - Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor - GlobeNewsWire
- 5 months ago - Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights - GlobeNewsWire